This will be a Joint Webinar involving GIRFT Pathology, Bedfordshire Hospitals Laboratory Clinical Lead and Deputy MD and EQA experts from Birmingham Quality and Weqas.

This webinar will be on Zoom and is free to attend. It is aimed at Heads of Departments and other influential stakeholders; however, everyone is welcome to attend, but you must register individually.

We will focus on what lessons, we as a profession, can learn from recent HbA1c events and the impact on the patient perspective. Real patient experiences will be used to drive a debate which we invite you to ask questions via the registration process (see QR code above).

Please book by midnight Sunday 9th November to secure your place!

Register Now

Topics and Speakers include:

• Martin Myers (GIRFT Pathology, Co-Lead)
  • Is our Quality Management System too focussed on Laboratory Processes, and not enough on
    what decisions are being made on the results?
  • How do we define what Analytical Performance Specifications are suitable for the use of a test?
• Dr Danielle B Freedman (Deputy Medical Director, Bedfordshire Hospitals NHS FT)
  • What is more important, Patients vs Laboratory Processes? (Debate)
• Dr David Housley (Clinical Lead for Clinical Biochemistry and Immunology, Bedfordshire Hospitals NHS FT)
  • The laboratory perspective, how to make best use of the resources that you already have available
• Annette Thomas (Director, Weqas)
  • Analytical Performance Specifications, who is responsible? What is suitable?
• Finlay MacKenzie (Director, Birmingham Quality)
  • ‘It’s Science, not magic’ and the Missing Piece in current governance